Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ROXANNA LEE GUNNELS

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1639778160
CMS profile
11196493
Location
CARMI, IL

General Payments · PY2021–2024

$1,243.61

  • Reported across 87 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$246.99

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $246.99 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ITI, Inc. $150.01 8
Acerta Pharma LLC $42.14 3
ABBVIE INC. $19.80 1
Novo Nordisk AS $17.81 1
Neurocrine BioSciences, Inc. $17.23 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $349.79 28
PY2022 $363.31 24
PY2023 $283.52 21
PY2024 $246.99 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $19.80 10/01/2024 Food and Beverage Undisputed 01/23/2026 1107265267 CMS
AstraZeneca Pharmaceuticals LP $14.24 06/27/2024 Food and Beverage Undisputed 01/23/2026 1104225299 CMS
AstraZeneca Pharmaceuticals LP $13.85 08/15/2024 Food and Beverage Undisputed 01/23/2026 1105548045 CMS
AstraZeneca Pharmaceuticals LP $14.05 11/06/2024 Food and Beverage Undisputed 01/23/2026 1104499600 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9.50 02/29/2024 Food and Beverage Undisputed 01/23/2026 1143473116 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.12 04/18/2024 Food and Beverage Undisputed 01/23/2026 1143473122 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.00 05/17/2024 Food and Beverage Undisputed 01/23/2026 1143473128 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.68 06/20/2024 Food and Beverage Undisputed 01/23/2026 1143473133 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.39 07/26/2024 Food and Beverage Undisputed 01/23/2026 1143473139 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.75 08/30/2024 Food and Beverage Undisputed 01/23/2026 1143473145 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.66 10/21/2024 Food and Beverage Undisputed 01/23/2026 1143473151 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.91 12/16/2024 Food and Beverage Undisputed 01/23/2026 1143473156 CMS
Neurocrine Biosciences, Inc. $17.23 08/26/2024 Food and Beverage Undisputed 01/23/2026 1150993694 CMS
Novo Nordisk Inc $17.81 07/18/2024 Food and Beverage Undisputed 01/23/2026 1100226338 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.